Ameridose, sister company to the Framingham compounding pharmacy whose drugs have been implicated in the national fungal meningitis outbreak, has notified hundreds of workers they are being laid off Friday, as the company remains under a temporary closure order after regulators raised concerns about sterility practices there. The layoff affects 650 workers at Ameridose, a major supplier of injectable drugs to hospitals, and 140 at its affiliated marketing company, Medical Sales Management. Both companies share owners with New England Compounding Center.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help